Skip to main content
CWAN
NYSE Technology

Clearwater Analytics Reports Strong Revenue Growth Amidst $8.4B Acquisition and Strategic Investments

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
9
Price
$23.58
Mkt Cap
$6.78B
52W Low
$15.735
52W High
$32
Market data snapshot near publication time

summarizeSummary

Clearwater Analytics filed its annual 10-K, revealing substantial revenue and Adjusted EBITDA growth in 2025, alongside details of its pending $8.4 billion acquisition at a premium and over $2 billion in strategic acquisitions.


check_boxKey Events

  • Pending $8.4 Billion Acquisition Confirmed

    The company confirmed a definitive merger agreement from December 20, 2025, to be acquired for $24.55 per share, representing a premium to the current stock price. Early termination of the HSR waiting period was granted on February 13, 2026, with closing expected in Q2 2026.

  • Strong Revenue and Adjusted EBITDA Growth in 2025

    Clearwater Analytics reported a 62% increase in revenue to $731.4 million and a 70% increase in Adjusted EBITDA to $248.2 million for the year ended December 31, 2025, driven by new clients and expanded relationships.

  • Significant Acquisitions Drive Expansion and Costs

    The company completed over $2 billion in strategic acquisitions (Enfusion, Beacon, Bistro) in 2025, which expanded its product offerings and client base. These acquisitions, however, led to increased interest and depreciation/amortization expenses, contributing to a net loss of $40.3 million for the year.

  • Increased Indebtedness to Fund Acquisitions

    A new 2025 Credit Agreement was secured in April 2025, including an $800 million term loan and a $200 million revolving facility, replacing a prior agreement. This substantial increase in borrowings resulted in significantly higher interest expense.


auto_awesomeAnalysis

Clearwater Analytics' 10-K filing provides a comprehensive overview of its 2025 performance, highlighted by a definitive merger agreement to be acquired for approximately $8.4 billion at $24.55 per share, a premium to the current stock price. This follows the recent disclosure of early HSR waiting period termination. The company demonstrated robust operational growth with a 62% increase in revenue to $731.4 million and a 70% rise in Adjusted EBITDA to $248.2 million. This growth was significantly fueled by over $2 billion in strategic acquisitions (Enfusion, Beacon, Bistro), which expanded its product offerings and client base. However, these acquisitions also led to a substantial increase in interest expense from new borrowings and higher depreciation/amortization, contributing to a net loss of $40.3 million for the year, compared to a net income in the prior year that included a large deferred tax benefit. Investors should focus on the positive implications of the pending merger and the strong underlying business expansion, while understanding the accounting impact of the strategic investments on net income.

At the time of this filing, CWAN was trading at $23.58 on NYSE in the Technology sector, with a market capitalization of approximately $6.8B. The 52-week trading range was $15.74 to $32.00. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CWAN - Latest Insights

CWAN
Apr 09, 2026, 4:15 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CWAN
Apr 08, 2026, 7:58 AM EDT
Filing Type: SC 13E3/A
Importance Score:
7
CWAN
Apr 08, 2026, 6:55 AM EDT
Filing Type: DEFM14A
Importance Score:
9
CWAN
Apr 03, 2026, 6:59 AM EDT
Filing Type: PRER14A
Importance Score:
8
CWAN
Feb 24, 2026, 5:20 PM EST
Filing Type: SC 13E3
Importance Score:
9
CWAN
Feb 24, 2026, 4:14 PM EST
Filing Type: PREM14A
Importance Score:
9
CWAN
Feb 18, 2026, 4:27 PM EST
Filing Type: 10-K
Importance Score:
9
CWAN
Feb 17, 2026, 4:10 PM EST
Filing Type: DEFA14A
Importance Score:
8
CWAN
Jan 23, 2026, 5:23 PM EST
Filing Type: 8-K
Importance Score:
8